Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota in patients with Parkinson's disease in southern China
Aiqun Lin, Wenxia Zheng, Yan He, et al.
Parkinsonism & Related Disorders (2018) Vol. 53, pp. 82-88
Closed Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

Role and Mechanism of Gut Microbiota in Human Disease
Yinwei Chen, Jinghua Zhou, Li Wang
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 438
A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice
Timothy R. Sampson, Collin Challis, Neha Jain, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 338
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
Michela Barichella, Marco Severgnini, Roberto Cilia, et al.
Movement Disorders (2018) Vol. 34, Iss. 3, pp. 396-405
Closed Access | Times Cited: 326
Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota
Runzhi Chen, Ying Xu, Peng Wu, et al.
Pharmacological Research (2019) Vol. 148, pp. 104403-104403
Closed Access | Times Cited: 304
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Velma T. E. Aho, Pedro A. B. Pereira, Sari Voutilainen, et al.
EBioMedicine (2019) Vol. 44, pp. 691-707
Open Access | Times Cited: 294
Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease
Hiroshi Nishiwaki, Mikako Ito, Tomohiro Ishida, et al.
Movement Disorders (2020) Vol. 35, Iss. 9, pp. 1626-1635
Open Access | Times Cited: 271
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
Sarah Vascellari, Vanessa Palmas, Marta Melis, et al.
mSystems (2020) Vol. 5, Iss. 5
Open Access | Times Cited: 224
Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
Yaping Shao, Weidong Le
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 208
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
Zachary D. Wallen, Mary Appah, Marissa Dean, et al.
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 188
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Qing Wang, Yuqi Luo, К. Ray Chaudhuri, et al.
Brain (2021) Vol. 144, Iss. 9, pp. 2571-2593
Open Access | Times Cited: 186
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Federico Baldini, Johannes Hertel, Estelle Sandt, et al.
BMC Biology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 185
The Microbiome as a Modifier of Neurodegenerative Disease Risk
Ping Fang, Sabeen A. Kazmi, Kelly G. Jameson, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 201-222
Open Access | Times Cited: 185
Dysbiosis of gut microbiota in a selected population of Parkinson's patients
Daniele Pietrucci, Rocco Cerroni, Valeria Unida, et al.
Parkinsonism & Related Disorders (2019) Vol. 65, pp. 124-130
Closed Access | Times Cited: 178
Gut microbiota and aging
Zongxin Ling, Xia Liu, Yiwen Cheng, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 62, Iss. 13, pp. 3509-3534
Closed Access | Times Cited: 172
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis
Ting Shen, Yumei Yue, Tingting He, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 168
Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review
Jeffrey M. Boertien, Pedro A. B. Pereira, Velma T. E. Aho, et al.
Journal of Parkinson s Disease (2019) Vol. 9, Iss. s2, pp. S297-S312
Open Access | Times Cited: 160
Parkinson’s disease and the gastrointestinal microbiome
Michal Lubomski, Ai Huey Tan, Shen‐Yang Lim, et al.
Journal of Neurology (2019) Vol. 267, Iss. 9, pp. 2507-2523
Closed Access | Times Cited: 149
Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
Yaping Shao, Tianbai Li, Zheyi Liu, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 149
Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders
Laura Mitrea, Silvia Amalia Nemeş, Katalin Szabo, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 145
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease
Kari Murros, Vy A. Huynh, Timo M. Takala, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 138
Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease
Simon Spichak, Thomaz F. S. Bastiaanssen, Kirsten Berding, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 698-761
Open Access | Times Cited: 106
Gut bacterial profiles in Parkinson's disease: A systematic review
Zhe Li, Hongfeng Liang, Yingyu Hu, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 29, Iss. 1, pp. 140-157
Open Access | Times Cited: 105
Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review
Rebecca J. Solch, Julia O. Aigbogun, Andrew G. Voyiadjis, et al.
Journal of the Neurological Sciences (2022) Vol. 434, pp. 120166-120166
Open Access | Times Cited: 78
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
Hiroshi Nishiwaki, Mikako Ito, Tomonari Hamaguchi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top